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Abstract  
Introduction: There is not enough and comprehensive evidence on signs and symptoms of COVID-19; 
therefore, it seems too early to provide an appropriate clinical decision-making rule for this newly emerged 
pandemic viral disease.  
Objective: We tried to categorize patients’ signs and symptoms from very highly suspected to non-suspected, 
regarding having COVID-19.  
Methods: Most recently published English-language articles on COVID-19, were reviewed by the 
researchers. We considered each complaint, separately, and gathered available data, such as percentage of 
involved patients and their crude number. Then we considered the pooled and collected results as the final 
percentage of the occurrence of every specific symptom. We categorized patients’ complaints into six types, 
based on the data obtained. All extracted complaints were categorized and scored. 
Results: Twenty-seven articles were reviewed, of which, 12 considered for analysis. The selected papers 
had reported various numbers of patients, ranging from 16 to 1,099 patients (mean=229 patients per study). 
In total, nineteen different complaints, with an average of nine complaints per article, had been reported 
(IQR= 8-11). In terms of overall prevalence, based on the total number of patients, fever and dry cough were 
reported in more than half of the referred patients. The complaints were categorized in six types with and 
scored. 
Conclusions: The patients with score ≥17 are very highly suspected to COVID-19; However, patients with 
score <5 could be considered as non-suspected to COVID-19.  
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INTRODUCTION
The world has been entrapped with a new Corona 
Virus Disease (COVID-19) since early 2020. Most of 
the signs and symptoms caused by the new 
coronavirus are similar to other upper respiratory 
diseases. Although most of the reported complaints 
were related to upper and lower respiratory tracts, 
recently, some gastrointestinal and even 
dermatologic problems have emerged as chief 
complaints in some patients (1-4). Like other 
physicians, emergency medicine professionals 
need to know the prevalence and importance of 
each symptom in patients suffering from COVID-
19, and decide which patients should be considered 
as definite or suspected cases of COVID-19 (5). 
There is not enough and comprehensive evidence 
on signs and symptoms of COVID-19; therefore, it 
seems too early to provide an appropriate clinical 
decision-making rule for this newly emerged 
pandemic viral disease. In this study, by reviewing 
recently published papers, we tried to categorize 
patients’ signs and symptoms from very highly 
suspected to non-suspected, regarding having 
COVID-19. 
Methods 
Most recently published English-language articles 
on COVID-19, were reviewed by the researchers. 
All papers that reported signs and symptoms of 
patients who had referred to the hospitals 
(inpatients or outpatients), especially emergency 
departments, were included in this study. 
Exclusion criteria were as follows: articles that 
reported pediatric patients, and those that did not 
mention the number of patients. The only 
exception was WHO coronavirus article (1). The 
research team decided not to exclude this article 
considering its valuable data on the percentage of 
symptoms. Furthermore, we only used the 
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reported percentages of the patients` complaints in 
this paper and did not add them to the pooled 
database. We considered each complaint, 
separately, and gathered available data, such as 
percentage of involved patients and their crude 
number. Then we considered the pooled and 
collected results as the final percentage of the 
occurrence of every specific symptom. Thereafter, 
we categorized patients’ complaints into six types, 
based on the data obtained. All extracted 
complaints were categorized based on three main 
variables: the overall percentage of the patients 
with a particular symptom, the number of articles 
that reported each complaint, which could indicate 
the distribution of that particular complaint in 
various populations, and the importance of the 
complaints for diagnosis of COVID-19. For each 
type, a score of zero to three was given to each of 
the 3 mentioned variables, based on their power. 
Results 
Twenty-seven articles were reviewed, thirteen of 
which were excluded due to not reporting the 
number or percentage of different signs and 
symptoms in COVID-19 patients. Two other articles 
with the subject of COVID-19 in pediatrics were 
also excluded. In the end, 12 studies (1-3, 6-14) met our 
inclusion criteria and were analyzed. The selected 
Table 1: Complaints reported by selected articles 
Sign or Symptoms No. of Studies* 
Total 
patients 
Min 
(%) 
Max 
(%) 
Crude mean 
(%)** 
Pooled mean 
(%)*** 
Fever 12 (1-3, 6-14) 2527 61 98.6 81.5 81.8 
Dry cough 11 (1-3, 6-13) 2270 48 82 63.6 66.2 
Shortness of breath 10 (1-3,6,8,9, 11-14) 2353 3.3 31.2 24.4 16.35 
All 3 above 3 (2,6,11) 305 14.7 15 14.85 14.7 
Fatigue 9 (1-3,8,10-14) 2293 5.9 68 36.3 34.69 
Sore throat 9 (1-3,6,8-11,13) 2235 5 31.2 17.4 13.75 
Sputum in cough 8 (1-3,7-9,11,13) 2051 17 39.2 36.2 33.05 
Headache 7 (1-3,8,10,11,13) 2013 3.9 21.6 12.4 11.73 
Myalgia and/or arthralgia 7 (1-3,6,8,10,11) 2192 10.5 34.8 22.65 15.39 
Diarrhea 9 (1-3,8,-13) 1558 2 32.5 17.25 9.97 
Nasal congestion 5 (11,12,15,17,1) 776 2.7 6.1 5 5.48 
Nausea and/or vomiting 5 (1-3,8,12) 1336 1 13.7 7.35 7.01 
Hemoptysis 3 (1,3,14) 1869 0.9 4 2.45 1.4 
Anorexia 3 (2,8,12) 309 5.9 39.9 19.3 37.5 
Chills 3 (1,3,11) 1099 11.4 11.5 11.45 11.5 
Confusion 2 (6,14) 305 9 34 21.5 25.9 
Dizziness  3 (8,9,11) 154 9.4 12.5 10.95 11 
Abdominal pain 3 (2,8,12) 344 2.2 4.4 3.3 3.51 
Tonsil swelling 1 (3) 1099 2.1 2.1 2.1 2.1 
Weakness  1(9) 16 31.25 31.25 31.25 31.25 
Belching 1 (12) 120 5 5 5 5 
* Number of articles that reported each complaint 
** Average percentage of reported complaints  
*** The mean percentage calculated via pooling of data from various studies and dividing the total number of patients with a particular 
symptom to the total number of patients reported in the articles that reported that particular symptom 
 
Table 2: Categorization of complaints reported in the selected articles 
Types of 
Complaints 
Number of 
articles that 
reported the 
Complaints 
(point) 
Number of 
involved patients 
(point) 
Importance of the 
complaints in COVID-
19 diagnosis 
(point) 
Original Samples 
Final 
Points 
(0 – 9) 
TYPE I Nearly all (3) More than 65% (3) 
Very Common and 
Definitive(3) 
Fever, Cough, Shortness of 
Breath 
9 
TYPE II Most of them (2) 33% (2) 
Common and highly 
suspective (2) 
Fatigue, Sore Throat, Sputum 
in Cough 
6 
TYPE III More than half (1) 10 - 15% (1) 
Not common but 
suspective (0) 
Headache, Myalgia and or 
Arthralgia, Diarrhea 
2 
TYPE IV Less than half (0) 5 - 7% (0) 
Not Common, Non- 
suspective (0) 
Nasal Congestion, Nausea and 
or Vomiting, Hemoptysis 
0 
TYPE V a small number (0) 25 – 35% (1) 
Common in some areas, 
suspective (1) 
Anorexia, confusion, weakness 2 
TYPE VI A rare number (0) Less than 10% (0) Rare, non-suspective (0) 
Chills, dizziness, belching, 
tonsil swelling 
0 
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papers had reported various numbers of patients, 
ranging from 16 to 1,099 patients (mean=229 
patients per study). Two articles (7, 14) covered only 
three major symptoms, but three articles had 
reported thirteen different symptoms, some of 
which were very rare. In total, nineteen different 
complaints, with an average of nine complaints per 
article, had been reported (IQR= 8-11). In terms of 
overall prevalence, based on the total number of 
patients, fever and dry cough were reported in 
more than half of the referred patients. Table 1 
demonstrates all complaints reported by the 
patients. Table 2 demonstrates the categorization 
of all extracted complaints. Table 3 reveals the 
categorization of COVID-19 patients from very 
highly suspected to non-suspected cases according 
to the final points in table 2.  
DISCUSSION 
Although there is not enough available data for 
calculating sensitivity, specificity and positive 
likelihood ratio of every sign or symptom, some 
recommendations are made in this study, 
according to the findings are reported in table 2. It 
is recommended that emergency medicine 
specialists who encounter patients with at least 
two TYPE-I complaints or one TYPE I + two TYPE II 
complaints consider them a known case of COVID-
19, and take serious preventive and diagnostic 
measures regarding these patients. Although being 
in contact with a known or suspected case of 
COVID-19 could be very useful for identification of 
new cases (1, 15) many patients deny any close 
contact with such well-defined cases. Table 3 
demonstrates the categorization of COVID-19 
patients from very highly suspected to non-
suspected cases according to the final points in 
table 2. Therefore, physicians should rate every 
patient and consider the recommended approach 
in their practice. Although the above-mentioned 
approach, obtained through this study, requires 
further clinical research, using the given advice 
does not seem utterly illogical. 
CONCLUSIONS 
The patients with score ≥17 are very highly 
suspected to COVID-19; However, patients with 
score <5 could be considered as non-suspected to 
COVID-19 
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